Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 21833P301
Event date: 2026-10-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Asset Management, LP
Shares: 1,500,000 · Class: 7.76%
- Chen Bihua
Shares: 1,500,000 · Class: 7.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-26-004181
- Form type
- SCHEDULE 13G/A
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Nov 02, 2026
- Reporting period
- Oct 31, 2026
- Description
- Schedule 13G beneficial ownership